tsRNA signatures in cancer V Balatti, G Nigita, D Veneziano, A Drusco, GS Stein, TL Messier, ... Proceedings of the National Academy of Sciences 114 (30), 8071-8076, 2017 | 228 | 2017 |
Dysregulation of a family of short noncoding RNAs, tsRNAs, in human cancer Y Pekarsky, V Balatti, A Palamarchuk, L Rizzotto, D Veneziano, G Nigita, ... Proceedings of the National Academy of Sciences 113 (18), 5071-5076, 2016 | 214 | 2016 |
miRandola: Extracellular Circulating MicroRNAs Database AF Francesco Russo, Sebastiano Di Bella, Giovanni PLoS ONE 7 (10), e47786, 2012 | 191* | 2012 |
miRandola: extracellular circulating microRNAs database F Russo, S Di Bella, G Nigita, V Macca, A Laganà, R Giugno, A Pulvirenti, ... EMBnet. journal 18 (A), p. 135, 2012 | 191 | 2012 |
Circulating miR-106b-3p, miR-101-3p and miR-1246 as diagnostic biomarkers of hepatocellular carcinoma F Moshiri, A Salvi, L Gramantieri, A Sangiovanni, P Guerriero, G De Petro, ... Oncotarget 9 (20), 15350, 2018 | 89 | 2018 |
Noncoding RNA: current deep sequencing data analysis approaches and challenges D Veneziano, S Di Bella, G Nigita, A Lagana, A Ferro, CM Croce Human mutation 37 (12), 1283-1298, 2016 | 85 | 2016 |
Computational approaches for the analysis of ncRNA through deep sequencing techniques D Veneziano, G Nigita, A Ferro Frontiers in bioengineering and biotechnology 3, 77, 2015 | 79 | 2015 |
The MicroRNA family gets wider: the IsomiRs classification and role L Tomasello, R Distefano, G Nigita, CM Croce Frontiers in cell and developmental biology 9, 668648, 2021 | 76 | 2021 |
miRandola 2017: a curated knowledge base of non-invasive biomarkers F Russo, S Di Bella, F Vannini, G Berti, F Scoyni, HV Cook, A Santos, ... Nucleic acids research 46 (D1), D354-D359, 2018 | 71 | 2018 |
Reprogramming miRNAs global expression orchestrates development of drug resistance in BRAF mutated melanoma L Fattore, CF Ruggiero, ME Pisanu, D Liguoro, A Cerri, S Costantini, ... Cell Death & Differentiation 26 (7), 1267-1282, 2019 | 62 | 2019 |
A-to-I RNA editing: current knowledge sources and computational approaches with special emphasis on non-coding RNA molecules G Nigita, D Veneziano, A Ferro Frontiers in Bioengineering and Biotechnology 3, 37, 2015 | 62 | 2015 |
Selective targeting of point-mutated KRAS through artificial microRNAs M Acunzo, G Romano, G Nigita, D Veneziano, L Fattore, A Laganà, ... Proceedings of the National Academy of Sciences 114 (21), E4203-E4212, 2017 | 52 | 2017 |
microRNA editing in seed region aligns with cellular changes in hypoxic conditions G Nigita, M Acunzo, G Romano, D Veneziano, A Lagana, M Vitiello, ... Nucleic acids research 44 (13), 6298-6308, 2016 | 50 | 2016 |
RNA methylation in ncRNA: classes, detection, and molecular associations G Romano, D Veneziano, G Nigita, SP Nana-Sinkam Frontiers in Genetics 9, 243, 2018 | 48 | 2018 |
Tissue and exosomal miRNA editing in non-small cell lung cancer G Nigita, R Distefano, D Veneziano, G Romano, M Rahman, K Wang, ... Scientific reports 8 (1), 10222, 2018 | 44 | 2018 |
Identification of tRNA-derived ncRNAs in TCGA and NCI-60 panel cell lines and development of the public database tRFexplorer A La Ferlita, S Alaimo, D Veneziano, G Nigita, V Balatti, CM Croce, ... Database 2019, baz115, 2019 | 41 | 2019 |
Knockout of both miR-15/16 loci induces acute myeloid leukemia F Lovat, M Fassan, D Sacchi, P Ranganathan, A Palamarchuk, M Bill, ... Proceedings of the National Academy of Sciences 115 (51), 13069-13074, 2018 | 40 | 2018 |
MAPK15 upregulation promotes cell proliferation and prevents DNA damage in male germ cell tumors M Rossi, D Colecchia, G Ilardi, M Acunzo, G Nigita, F Sasdelli, A Celetti, ... Oncotarget 7 (15), 20981, 2016 | 40 | 2016 |
The TLR7/8/9 antagonist IMO-8503 inhibits cancer-induced cachexia F Calore, P Londhe, P Fadda, G Nigita, L Casadei, GP Marceca, ... Cancer research 78 (23), 6680-6690, 2018 | 37 | 2018 |
MicroRNA fingerprints in juvenile myelomonocytic leukemia (JMML) identified miR-150-5p as a tumor suppressor and potential target for treatment PP Leoncini, A Bertaina, D Papaioannou, C Flotho, R Masetti, S Bresolin, ... Oncotarget 7 (34), 55395, 2016 | 35 | 2016 |